Special Drug Use Survey of HERNICORE 1.25 units for intradiscal injection in Patients with Lumbar Disc Herniatio
Not Applicable
- Conditions
- umbar Disc Herniation
- Registration Number
- JPRN-UMIN000034724
- Lead Sponsor
- SEIKAGAKU CORPORATIO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1862
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety - Occurrence of adverse events and adverse reactions - Occurrence of post-treatment surgery for lumbar spinal instability at the same level of administration of HERNICORE Efficacy - Improvement of leg pain and low back pain - Occurrence of post-treatment surgery for lumbar disc herniation at the same level of administration of HERNICORE - Global assessment (physician) - Effects on long-term prognosis (e.g., recurrence of herniation, osteophyte formation, spinal canal stenosis)
- Secondary Outcome Measures
Name Time Method